Trial intelligence / Profile preview

Different Volumes for US-Guided Adductor Canal Block After Total Knee Arthroplasty

NCT06084403Completed

Sponsor
Bursa City Hospital
Start
Dec 2023
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by Bursa City Hospital. Primary endpoint: Postoperative opioid consumption at 48 hours. Started Dec 2023; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06084403.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06084403.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call